MedTrace Logo

Transdiagnostic Oncology Program in Primary Care

NCT06809452 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2025-02-10

No results posted yet for this study

Summary

The goal of this observational study is to learn about how cancer survivors experience a relatively new 12-month interdisciplinary aftercare program called the Transdiagnostic Oncologic Program (TOP). TOP is an innovative program offered as part of routine family-doctor care among several practices in the province Drenthe, the Netherlands. It is coordinated by the family doctor and caried out by an interdisciplinary team, consisting of the family doctor, a physiotherapist, nutritionist, and optionally a psychologist. The main questions this study aims to answer are:

* Is TOP feasible and acceptable?
* Does TOP lead to improvements in quality of life in cancer survivors? Patients who were eligible for the program (n=54) were asked to participate in research as well. Everyone who participated in TOP (n=19) agreed to participate in this study as well. Those who declined participation (n=35), were asked to serve as controls, of which 16 agreed to do so.

Conditions

  • Cancer Survivor

Interventions

BEHAVIORAL

Transdiagnostic Oncologic Program

The "Transdiagnostic Oncology Program" (TOP) is a 12-month interdisciplinary aftercare program aimed at improving cancer survivors' quality of life by addressing common clinical issues. In the first three months, participants attended two weekly 1-hour exercise sessions led by physiotherapists. Once a week, this was followed by 1-hour mind-body therapy for stress reduction. A dietitian provided an initial group session on nutrition and advised at least two personal consultations. Between months 3-6, exercise was reduced to once weekly, with encouragement to continue independent exercise and relaxation. A second informational session on stress and sleep hygiene was given. After six months, participants continued independently, meeting the family doctor quarterly to evaluate progress. For the participants who experienced some psychological problems, sessions with a psychologist at an institute specialized for psycho-oncology, were available.

Sponsors & Collaborators

  • Dokter Drenthe

    collaborator UNKNOWN

  • University Medical Center Groningen

    collaborator OTHER

  • Kloosterveen, Assen

    collaborator UNKNOWN

  • Gezondheidscentrum Assen-Oost, Assen

    collaborator UNKNOWN

  • Lentis Psychiatric Institute

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2020-01-01
Completion
2020-01-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06809452 on ClinicalTrials.gov